Potential of oligonucleotide-mediated exon-skipping therapy for Duchenne muscular dystrophy

By Yokota Toshifumi   Pistilli Emidio   Duddy William   Nagaraju Kanneboyina  

Expert Opinion on Biological Therapy, Vol. 7, Iss. 6, 2007-06 ,pp. : 831-842

Informa Healthcare

Access to resources Recommend Favorite

The Concomitant Use of Dystrophin and Utrophin/Dystrophin Related Protein Antibodies to Reduce Misdiagnosis of Duchenne/Becker Muscular Dystrophy

By Khurana T.S.   Specht L.A.   Beggs A.H.   Tomé F.M.S.   Letureq F.   Chevallay M.   Chafey P.   Kunkel L.M.  

Biochemical and Biophysical Research Communications, Vol. 241, Iss. 2, 1997-12 ,pp. : 232-235

Elsevier

Access to resources Recommend Favorite

Skeletal Muscle of Patients with Duchenne's Muscular Dystrophy: Evidence of a Mitochondrial Proteolytic Factor Responsible for Calmitine Deficiency

By Lucas-Heron B.  

Biochemical and Biophysical Research Communications, Vol. 223, Iss. 1, 1996-06 ,pp. : 31-35

Elsevier

Access to resources Recommend Favorite

Absence of a Calmitine-Specific Protease Inhibitor in Skeletal Muscle Mitochondria of Patients with Duchenne's Muscular Dystrophy

By Lucas-Heron B.  

Biochemical and Biophysical Research Communications, Vol. 225, Iss. 3, 1996-08 ,pp. : 701-704

Elsevier

Access to resources Recommend Favorite

A Drug Inhibits the Mitochondrial Protease Inducing Calmitine Deficiency in Skeletal Muscle of Patients with Duchenne's Muscular Dystrophy and dy/dy Dystrophic Mice

By Lucas-Heron B.  

Biochemical and Biophysical Research Communications, Vol. 232, Iss. 2, 1997-03 ,pp. : 559-561

Elsevier

Access to resources Recommend Favorite